Lucy (Liuquan) Chang

Lucy Chang obtained her Ph.D. in Pharmaceutics from University of Connecticut and has 17 years of experience in pharmaceutical industry. She joined Merck in 2016 and currently serves as an Executive Director, Head of pre-approval team, Chemistry, Manufacturing & Controls (CMC), Biologics, Global Regulatory Affairs & Clinical Safety. In this role, she leads a team that is responsible for the regulatory strategy, global submission for all the biologics in development at Merck. She is also responsible for supporting all the new technology development and facility for the future for Biologics in Merck, developing innovative regulatory approaches that facilitate the implementation of the technologies with an eye towards commercialization.